Skip to content

    Vivos Therapeutics (VVOS) stock price & financials

    View VVOS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance95.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $3.86M
    $3.70M
    $3.02M
    $3.82M
    $6.78M
    +75.7%
    $3.82M
    +3.4%
    $5.14M
    +70.5%
    $5.15M
    +34.9%
    Strengthening
    Operating Profit
    -$2.65M
    -$2.81M
    -$3.92M
    -$4.87M
    -$4.73M
    -79.0%
    -$6.38M
    -127.3%
    -$6.62M
    -68.8%
    -$4.83M
    +0.8%
    Weakening
    Net Profit
    -$2.62M
    -$2.83M
    -$3.86M
    -$5.01M
    -$5.40M
    -106.4%
    -$6.89M
    -143.8%
    -$7.68M
    -98.8%
    -$5.48M
    -9.3%
    Weakening
    EPS
    $-0.40
    $-0.45
    $-0.55
    $-0.49
    -22.5%
    $-0.52
    -15.6%
    $-0.31
    +43.6%
    Strengthening
    Other Income
    Interest
    $500.0K
    $1.10M
    $1.10M
    Strengthening
    Depreciation
    Profit before Tax
    -$2.62M
    -$2.83M
    -$3.86M
    -$5.01M
    -$5.40M
    -106.4%
    -$6.95M
    -145.9%
    -$7.75M
    -100.6%
    -$5.52M
    -10.2%
    Weakening
    MarginsOPM
    -68.5%
    -75.8%
    -129.9%
    -127.4%
    -69.8%
    -1.9%
    -166.8%
    -119.9%
    -128.7%
    +1.0%
    -93.6%
    +26.5%
    Weakening
    Tax
    ReturnsROIC
    1.9%
    2.0%
    2.8%
    3.6%
    3.9%
    +106.4%
    5.0%
    +143.8%
    5.5%
    +98.8%
    4.0%
    +9.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$469.4K$18.21M$24.03M$3.52M$1.64M$6.26M$2.03M$1.77M
    Short-Term Investments
    Total Current Assets$1.98M$20.39M$27.32M$5.42M$2.46M$7.47M$4.38M$4.21M
    Net PP&E$1.14M$872.0K$2.83M$4.78M$4.70M$4.34M$7.92M$7.45M
    Goodwill$2.67M$2.67M$2.84M$2.84M$2.84M$2.84M$8.57M$8.57M
    Intangibles$689.2K$270.0K$341.0K$302.0K$420.0K$409.0K$4.04M$3.64M
    Total Assets$7.55M$25.33M$33.69M$13.72M$10.73M$15.28M$25.15M$24.14M
    LiabilitiesTotal Current Liabilities$9.09M$7.84M$7.51M$6.81M$7.29M$4.98M$18.08M$20.39M
    Short-Term Debt$3.71M$867.0K$1.26M$8.35M$7.77M
    Long-Term Debt$3.71M$423.0K$1.26M$469.0K$366.0K
    Long-Term Leases$641.0K$1.99M$1.52M$1.03M$3.84M$3.44M
    Total Liabilities$9.18M$8.41M$8.15M$8.92M$10.32M$7.33M$26.70M$28.13M
    EquityCommon Stock & APIC$1.2K$2.0K$2.0K$2.0K$1.0K$1.0K
    Retained Earnings-$23.28M-$35.34M-$55.62M-$79.47M-$93.05M-$104.19M-$125.36M-$138.52M
    Total Equity-$2.94M$16.92M$25.54M$4.80M$411.0K$7.95M-$1.49M-$3.81M
    HighlightsNet Cash / (Debt)-$6.95M$16.92M$21.50M-$6.79M-$6.36M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$5.34M-$5.68M-$15.73M-$19.59M-$11.95M-$12.69M-$15.26M-$17.13M
    Cash from Investing$86.2K-$120.0K-$2.61M-$924.0K-$853.0K-$568.0K-$7.53M-$1.93M
    Cash from Financing$4.47M$23.54M$24.17M$10.92M$17.88M$18.56M$16.43M
    SummaryCapital Expenditure-$175.6K-$120.0K-$2.40M-$924.0K-$803.0K-$568.0K-$2.34M-$1.88M
    Free Cash Flow-$5.52M-$5.80M-$18.13M-$20.51M-$12.75M-$13.26M-$17.60M-$19.01M
    FCF Margin-48.4%-44.4%-107.4%-128.0%-92.4%-88.2%-100.9%-91.0%

    Ratios